BIOCON
|
The Current P/B Ratio of BIOCON is 2.56.
| Share Price | ₹406.4 | Nov 12,2025 |
| Market Cap | ₹54,329.0 Cr | |
| Book Value | ₹21,219.1 Cr | Mar2025 - Consolidated Results |
| Price/Book | 2.56x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹54,329.0 Cr] as on Nov 12,2025
(/) Book Value [ ₹21,219.1 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.56x ]
Thus, for BIOCON , the investors are currently willing to pay '2.56 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.28x.
- BIOCON 's operated at median p/b ratio of 1.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| BIOCON | 21,219.10 | 2.56 | 54,329.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.75 | 415,529.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.56 | 173,067.0 |
| CIPLA LTD | 31,079.30 | 3.95 | 122,773.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 17.04 | 129,376.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.07 | 102,595.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.57 | 93,824.1 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.00 | 95,713.0 |
| LUPIN LTD | 17,119.50 | 5.43 | 92,989.9 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.11 | 69,007.9 |
| ABBOTT INDIA LTD | 4,204.27 | 14.94 | 62,818.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.11x |
| Max industry PB | 17.04x |
| Median industry PB | 5.43x |
| Average industry PB | 7.00x |
You may also like the below Video Courses